Jane Street Group LLC acquired a new stake in BlackRock Health Sciences Trust (NYSE:BME – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 8,589 shares of the company’s stock, valued at approximately $326,000.
Several other large investors also recently added to or reduced their stakes in BME. First Trust Advisors LP lifted its holdings in shares of BlackRock Health Sciences Trust by 6.1% during the 4th quarter. First Trust Advisors LP now owns 6,856 shares of the company’s stock worth $260,000 after acquiring an additional 393 shares during the last quarter. Comerica Bank raised its position in BlackRock Health Sciences Trust by 13.1% during the fourth quarter. Comerica Bank now owns 4,454 shares of the company’s stock valued at $169,000 after purchasing an additional 517 shares in the last quarter. NewEdge Advisors LLC lifted its stake in BlackRock Health Sciences Trust by 6.5% during the fourth quarter. NewEdge Advisors LLC now owns 14,388 shares of the company’s stock worth $546,000 after purchasing an additional 880 shares during the last quarter. HBK Sorce Advisory LLC boosted its holdings in shares of BlackRock Health Sciences Trust by 14.8% in the 4th quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock worth $311,000 after purchasing an additional 1,057 shares in the last quarter. Finally, Yakira Capital Management Inc. purchased a new position in shares of BlackRock Health Sciences Trust during the 4th quarter valued at about $322,000.
BlackRock Health Sciences Trust Stock Up 0.8%
Shares of BlackRock Health Sciences Trust stock opened at $36.18 on Tuesday. BlackRock Health Sciences Trust has a 52-week low of $34.18 and a 52-week high of $42.64. The company has a fifty day moving average of $36.40 and a 200-day moving average of $38.32.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- The Significance of Brokerage Rankings in Stock Selection
- Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead
- What Investors Need to Know About Upcoming IPOs
- Top 3 ETFs Defense Hawks Are Buying
- What is Put Option Volume?
- Zscaler Will Hit $360 Soon: Here’s the How and Why
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.